The Vaccine Group Limited
Private Limited Company · Cambridge
ActiveUnited KingdomIncorporated 2017Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-06-30
IXBRL · 160 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2025-06-30
IXBRL · 160 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-07-01 to 2025-06-30
- Extraction status
- complete
- Numeric facts
- 92
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2509_10842271_20250630
- Source archive
- Accounts_Monthly_Data-September2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-06-30
IXBRL · 159 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2024-06-30
IXBRL · 159 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2023-07-01 to 2024-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 92
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3100_10842271_20240630
- Source archive
- Accounts_Monthly_Data-November2024.zip
Accounts to 2023-06-30
IXBRL · 152 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2023-06-30
IXBRL · 152 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2022-07-01 to 2023-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 85
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- secr-frs-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0031_10842271_20230630
- Source archive
- Accounts_Monthly_Data-November2023.zip
Accounts to 2022-06-30
IXBRL · 148 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-06-30
IXBRL · 148 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-07-01 to 2022-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- secr-frs-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0009_10842271_20220630
- Source archive
- Accounts_Monthly_Data-March2023.zip
Accounts to 2021-06-30
IXBRL · 144 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-06-30
IXBRL · 144 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-07-01 to 2021-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 78
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0104_10842271_20210630
- Source archive
- Accounts_Monthly_Data-March2022.zip
Accounts to 2020-06-30
IXBRL · 147 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2020-06-30
IXBRL · 147 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2019-07-01 to 2020-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0091_10842271_20200630
- Source archive
- Accounts_Monthly_Data-June2021.zip
Accounts to 2019-06-30
IXBRL · 121 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2019-06-30
IXBRL · 121 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2018-07-01 to 2019-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 59
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0076_10842271_20190630
- Source archive
- Accounts_Monthly_Data-March2020.zip
Accounts to 2018-06-30
IXBRL · 25 source facts · 2 selected values
Not assessedlegacy record
Accounts to 2018-06-30
IXBRL · 25 source facts · 2 selected values
Not assessed
legacy record
- Reporting period
- 2017-06-29 to 2018-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 5
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0060_10842271_20180630
- Source archive
- Accounts_Monthly_Data-November2018.zip
Registered details
10842271- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2017-06-29
- Jurisdiction
- —
- Registered office
- THE OFFICERS’ MESS, ROYSTON ROAD, CAMBRIDGE, CB22 4QH, ENGLAND
Classification
1 SIC codes23006
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsAn innovative vaccine development platform that protects cattle against infectious diseases, improves welfare and reduces livestock-produced methaneLeadInnovate UK · Collaborative R&D · 2024-09-01 – 2026-03-31 · with 1 other participant£231,888awarded
An innovative vaccine development platform that protects cattle against infectious diseases, improves welfare and reduces livestock-produced methaneLead
Innovate UK · Collaborative R&D · 2024-09-01 – 2026-03-31 · with 1 other participant
£231,888
awarded
The Vaccine Group Limitedlead£231,888
Animal & Plant Health Agency£174,729
Novel enhanced Streptoccocus suis vaccine for pigs (II)LeadInnovate UK · Collaborative R&D · 2024-06-01 – 2026-05-31 · with 2 other participants£583,400awarded
Novel enhanced Streptoccocus suis vaccine for pigs (II)Lead
Innovate UK · Collaborative R&D · 2024-06-01 – 2026-05-31 · with 2 other participants
£583,400
awarded
The Vaccine Group Limitedlead£583,400
University of Plymouth£148,944
University of Cambridge£21,608
Development of attenuated bovine herpesvirus-4 as a safe, inexpensive, single dose vaccine to control Streptococcus suis infection in domestic pigsLeadInnovate UK · Collaborative R&D · 2019-04-01 – 2022-09-30 · with 1 other participant£403,434awarded
Development of attenuated bovine herpesvirus-4 as a safe, inexpensive, single dose vaccine to control Streptococcus suis infection in domestic pigsLead
Innovate UK · Collaborative R&D · 2019-04-01 – 2022-09-30 · with 1 other participant
£403,434
awarded
The Vaccine Group Limitedlead£403,434
University of Plymouth£294,350
University stake evidence
University Of Plymouth Enterprise Limited
psc · 25-50% band